Cargando…
DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
BACKGROUND: Chinese herbal formulae are composed of complex components and produce comprehensive pharmacological effects. Unlike chemical drugs that have only one clear single target, the components of Chinese herbal formulae have multiple channels and targets. How to discover the pharmacological ta...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933388/ https://www.ncbi.nlm.nih.gov/pubmed/24555740 http://dx.doi.org/10.1186/1472-6882-14-67 |
_version_ | 1782304925810688000 |
---|---|
author | Wang, Yong Li, Chun Liu, Zhongyang Shi, Tianjiao Wang, Qiyan Li, Dong Wu, Yan Han, Jing Guo, Shuzhen Tang, Binghua Wang, Wei |
author_facet | Wang, Yong Li, Chun Liu, Zhongyang Shi, Tianjiao Wang, Qiyan Li, Dong Wu, Yan Han, Jing Guo, Shuzhen Tang, Binghua Wang, Wei |
author_sort | Wang, Yong |
collection | PubMed |
description | BACKGROUND: Chinese herbal formulae are composed of complex components and produce comprehensive pharmacological effects. Unlike chemical drugs that have only one clear single target, the components of Chinese herbal formulae have multiple channels and targets. How to discover the pharmacological targets of Chinese herbal formulae and their underlying molecular mechanism are still under investigation. METHODS: DanQi pill (DQP), which is one of the widely prescribed traditional Chinese medicines, is applied as an example drug. In this study, we used the drug target prediction model (DrugCIPHER-CS) to examine the underlying molecular mechanism of DQP, followed by experimental validation. RESULTS: A novel therapeutic effect pattern of DQP was identified. After determining the compounds in DQP, we used DrugCIPHER-CS to predict their potential targets. These potential targets were significantly enriched in well-known cardiovascular disease-related pathways. For example, the biological processes of neuroactive ligand–receptor interaction, calcium-signaling pathway, and aminoacyl–tRNA biosynthesis were involved. A new and significant pathway, arachidonic acid (AA) metabolism, was also identified in this study. This predicted pathway alteration was validated with an animal model of heart failure (HF). Results show that DQP had effect both on thromboxane B2 (TXB2) and Prostaglandin I2 (PGI2) in different patterns. It can down-regulate the TXB2 and up-regulate the PGI2 in diverse way. Remarkably, it also had effect on cyclooxygenase (COX)-1 and COX2 by suppressing their levels, which may be the critical and novel mechanism of cardiacprotective efficacy for DQP. Furthermore, leukotrienes B4 (LTB4) receptor, another key molecule of AA metabolism which finally mediated gastrotoxic leukotrienes, was also reduced by DQP. CONCLUSIONS: The combination of drug target prediction and experimental validation provides new insights into the complicated mechanism of DQP. |
format | Online Article Text |
id | pubmed-3933388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39333882014-02-25 DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 Wang, Yong Li, Chun Liu, Zhongyang Shi, Tianjiao Wang, Qiyan Li, Dong Wu, Yan Han, Jing Guo, Shuzhen Tang, Binghua Wang, Wei BMC Complement Altern Med Research Article BACKGROUND: Chinese herbal formulae are composed of complex components and produce comprehensive pharmacological effects. Unlike chemical drugs that have only one clear single target, the components of Chinese herbal formulae have multiple channels and targets. How to discover the pharmacological targets of Chinese herbal formulae and their underlying molecular mechanism are still under investigation. METHODS: DanQi pill (DQP), which is one of the widely prescribed traditional Chinese medicines, is applied as an example drug. In this study, we used the drug target prediction model (DrugCIPHER-CS) to examine the underlying molecular mechanism of DQP, followed by experimental validation. RESULTS: A novel therapeutic effect pattern of DQP was identified. After determining the compounds in DQP, we used DrugCIPHER-CS to predict their potential targets. These potential targets were significantly enriched in well-known cardiovascular disease-related pathways. For example, the biological processes of neuroactive ligand–receptor interaction, calcium-signaling pathway, and aminoacyl–tRNA biosynthesis were involved. A new and significant pathway, arachidonic acid (AA) metabolism, was also identified in this study. This predicted pathway alteration was validated with an animal model of heart failure (HF). Results show that DQP had effect both on thromboxane B2 (TXB2) and Prostaglandin I2 (PGI2) in different patterns. It can down-regulate the TXB2 and up-regulate the PGI2 in diverse way. Remarkably, it also had effect on cyclooxygenase (COX)-1 and COX2 by suppressing their levels, which may be the critical and novel mechanism of cardiacprotective efficacy for DQP. Furthermore, leukotrienes B4 (LTB4) receptor, another key molecule of AA metabolism which finally mediated gastrotoxic leukotrienes, was also reduced by DQP. CONCLUSIONS: The combination of drug target prediction and experimental validation provides new insights into the complicated mechanism of DQP. BioMed Central 2014-02-20 /pmc/articles/PMC3933388/ /pubmed/24555740 http://dx.doi.org/10.1186/1472-6882-14-67 Text en Copyright © 2014 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wang, Yong Li, Chun Liu, Zhongyang Shi, Tianjiao Wang, Qiyan Li, Dong Wu, Yan Han, Jing Guo, Shuzhen Tang, Binghua Wang, Wei DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 |
title | DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 |
title_full | DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 |
title_fullStr | DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 |
title_full_unstemmed | DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 |
title_short | DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 |
title_sort | danqi pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes b4 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933388/ https://www.ncbi.nlm.nih.gov/pubmed/24555740 http://dx.doi.org/10.1186/1472-6882-14-67 |
work_keys_str_mv | AT wangyong danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT lichun danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT liuzhongyang danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT shitianjiao danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT wangqiyan danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT lidong danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT wuyan danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT hanjing danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT guoshuzhen danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT tangbinghua danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 AT wangwei danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4 |